[Bevacizumab and lung cancer: eligible patients in daily practice].
Lagnien-Gaume V, Jehl J, Manzoni P, Jacoulet P, Gainet-Brun M, Metzger F, Pernet D, Polio JC, Pugin JF, Corgne J, Amoros C, Dalphin JC, Westeel V.
Lagnien-Gaume V, et al. Among authors: pernet d.
Rev Mal Respir. 2011 Jan;28(1):25-31. doi: 10.1016/j.rmr.2010.05.016. Epub 2011 Jan 17.
Rev Mal Respir. 2011.
PMID: 21277471
French.